Vaxcyte Inc at Needham Healthcare Conference (Virtual) Transcript
Good afternoon, everyone. Thank you for joining the 21st Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company, Vaxcyte. Joining us today from Vaxcyte is CEO, Grant Pickering; and COO, Jim Wassil. (Operator Instructions)
With that, we'll get started. I'll turn it over to Grant for some opening remarks, and then we'll start the chat.
Great. Thank you, Joey. Delighted to be participating in the Needham conference. We really appreciate you including us. And I guess I'll just start out by saying I'm expecting that we'll be making some forward-looking statements over the course of this conversation and would direct you to the sec.gov page for our filings so you can have a more complete and balanced perspective on our business. And would just like to say that 2022 is going to be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |